BNP Paribas Financial Markets’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

BNP Paribas Financial Markets’s Portfolio OCEA Stock Details OCEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-143	Closed	-$8	–	5727
2025 Q1	$8	Hold	143	–	–	﹤0.01%	5346
2024 Q4	$79	Buy	+143	New	+$113	﹤0.01%	5294

Other funds holding OCEA

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

VPIM

Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

SMA

Sage Mountain Advisors Atlanta, Georgia $1.63B AUM 18.97% 1-Year Est. Return

BNP Paribas Financial Markets's OCEA Position: Q2 2025 in Review

BNP Paribas Financial Markets sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2025, closing a stake of 143 shares — an estimated $8 sold.

BNP Paribas Financial Markets first reported a position in OCEA in Q4 2024 and held it in 2 quarters. The position peaked at $79 in Q4 2024. 7 funds tracked by Wall St. Rank hold OCEA as of Q2 2025.

BNP Paribas Financial Markets reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
BNP Paribas Financial Markets sold 143 Ocean Biomedical, Inc. Common Stock shares in Q2 2025, an estimated $8.
BNP Paribas Financial Markets first reported a position in Ocean Biomedical, Inc. Common Stock in Q4 2024 and held it in 2 quarters.
BNP Paribas Financial Markets's Ocean Biomedical, Inc. Common Stock position peaked at $79 in Q4 2024.
7 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2025, filed 14 Aug 2025.